Date Announced: 08 Oct 2013
Company Milestone Shows Positive Global Response to its Laser Therapeutics.
CLERMONT-FERRAND, France, Oct. 8, 2013 /PRNewswire/ -- Quantel Medical, a world leader in ophthalmic ultrasound and laser devices, today announced that it recently sold its 400th Multispot laser for the treatment of retinal disease, including, among others, diabetic macular edema (DME), central serous retinopathy and retinal vein occlusion (RVO). Quantel's two Multispot laser systems – the SupraScan™ 577 and Vitra Multispot™ – offer a comprehensive range of treatment patterns in conjunction with precisely controlled laser emission, providing an improved experience for both patient and physician.
Both Multispot lasers leverage pattern-scanning technology to achieve optimal treatment results. Short, 10-20ms pulses are placed in a variety of potential patterns, resulting in reduced heat diffusion to the retina and choroid and, subsequently, reduced collateral damage to surrounding tissue. Multispot treatment is characterized by a more comfortable experience for patients, extremely efficient treatment (full pan-retinal photocoagulation (PRP) is possible in 2 sessions), and shorter laser sessions, when compared to traditional laser treatment.
"The sale of our 400th Multispot laser constitutes a critical milestone for Quantel," noted Mr. Jean-Marc Gendre, CEO of Quantel Medical. "Quantel's pattern-scanning laser technologies provide retinal specialists and comprehensive ophthalmologists the highest-quality technology to achieve optimum treatment results. As we continue to innovate, we will bring additional best-in-class technologies to ophthalmologists across the world."
The SupraScan 577 is a 577nm photocoagulation laser that adapts to Haag Streit-type slit lamps. 577nm wavelength treatment is both efficient and efficacious, utilizing less power during treatment and achieving excellent combined absorption by both melanin and oxyhemoglobin, making 577nm an ideal choice for penetrating cataracts and hazy media. Additionally, the system is capable of performing MicroPulse™*, a tissue-sparing treatment mode that segments laser delivery into a sequence of extremely short, microsecond pulses.
The Vitra Multispot is a 532nm portable multispot laser that also adapts to Haag Streit-type slit lamps. The system utilizes electronically controlled laser emissions based on the "Start and Stop" principle: unlike other lasers, the system does not use galvo mirrors to control pulse duration, resulting in a laser beam always perfectly centered in the fiber and laser pulses generated and controlled by the laser itself. Subsequently, this technology ensures excellent spot-to-spot laser burn consistency, and that fluence is controlled and consistent for each spot.
Source: Quantel Medical
E-mail: via web site
Web Site: www.quantel-medical.com
© 2024 SPIE Europe |
|